comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 03:24:35 - browse：971

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Study: Black kids more likely to die after surgery than white kids

focus

entertainment

WSS

Insurer loopholes limit power of law against surprise medical bills

Bird flu in dairy cattle: New measures to control spread to humans

As a primary care physician, here's how I hope to partner with AI

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Drug companies' payments and gifts affect physicians' prescribing

Hundreds died while taking an arthritis drug, but nobody alerted patients

explore

comprehensive

focus

Wildfire smoke exposes gaps in outdoor worker protections

Fentanyl is making it harder to start addiction treatment

Cancer drug shortages should be causing more outrage

Insurer loopholes limit power of law against surprise medical bills

Hepatitis C has a cure — but many Americans still lack access to it

Scrutiny of post

Trump demands the U.S. pay no more for drugs than other countries … again

Young boy dies in trial for Pfizer Duchenne gene therapy

Activists slam private health insurers over coverage restrictions

Making the case for fair compensation in clinical trials

hotspot

Oral obesity drug from Viking Therapeutics hits key early target

Oral obesity drug from Viking Therapeutics hits key early target

Covid silver lining: Unprecedented look at human immune system

Biogen joins immunology wave with $1.15 billion acquisition of HI

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Investigation reveals sickle cell patients pressured into sterilizations

focus

focus

entertainment

leisure time